Recognizing MacTel Masquerades - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Recognizing MacTel Masquerades

Imaging features such as retinal thinning and ellipsoid zone loss can help differentiate MacTel from AMD and related retinal diseases.

  • By

  • Jay Chhablani, MD

  • May 14, 2026

  • 2 min

Share

Objective:

To differentiate macular telangiectasia type 2 (MacTel) from age-related macular degeneration (AMD) and other retinal diseases using imaging features.

Key Findings:
  • MacTel features retinal thinning and ellipsoid zone loss.
  • AMD typically shows signs of drusen and choroidal neovascularization (CNV).
  • MacTel involves neurodegeneration, leading to distinct imaging characteristics.
Interpretation:

The subtlety of MacTel makes it challenging to diagnose, necessitating careful analysis of imaging features to avoid misdiagnosis.

Limitations:
  • The presentation may not cover all potential overlapping features with other diseases.
  • Reliance on multimodal imaging may not be accessible in all clinical settings.
Conclusion:

Understanding the imaging characteristics of MacTel is crucial for accurate diagnosis and differentiation from similar retinal diseases.

Original Source(s)

Recognizing MacTel Masquerades

  • by Jay Chhablani, MD

  • May 14, 2026

Related Content

Expanding Imaging Capabilities

Optos’ new Silverstone platform seeks to narrow the gap between visualization and structural insight in retinal imaging

  • June 1, 2026

  • 3 min
Stuart Therapeutics Spotlights Topical RP Program

At OIS Retina, Eric Schlumpf discussed the company’s collagen mimetic peptide platform for retinitis pigmentosa, now in preclinical development.

FDA Monthly Preview: Key May Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.